Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0001062993-23-022200

Chief Development Officer bought 5,000 shares at $3.73 ($18,662)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Shankar Gopi Chief Development Officer 2023-12-07 Purchase +5,000 $3.73 $18,662 5,000 D: show line 1 in the form
Open-market purchases · 5,000 sh · avg $3.73 · $18,662
Loading xslF345X05/form4.xml…